Urological Drug Price Stewardship: Potential Cost Savings Based on the Mark Cuban Cost Plus Drug Company Model

被引：14
|
作者：
Cortese, Brian D. [1 ]
Chang, Sam S. [2 ]
Talwar, Ruchika [2 ]
机构：
[1] Univ Penn Hlth Syst, Div Urol, Dept Surg, Philadelphia, PA USA
[2] Vanderbilt Univ, Dept Urol Surg, Nashville, TN USA
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷 / 02期
关键词：
Medicare Part D; health policy; drug prescriptions; drugs; generic; drug costs;
D O I：
10.1097/JU.0000000000003083
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：309 / 311
页数：3
相关论文
共 50 条
  • [41] Forecasting Global Essential Childhood Cancer Drug Need and Cost: An Innovative Model-Based Approach
    Empringham, B.
    Hughes, T.
    Gupta, S.
    Wagner, A.
    Ward, Z.
    Yeh, J.
    Frazier, A. L.
    Denburg, A.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S246 - S247
  • [42] Model helps guide cost-effective drug use under outcomes-based reimbursement
    不详
    FORMULARY, 2000, 35 (11) : 877 - 877
  • [43] Forecasting Global Essential Childhood Cancer Drug Need and Cost: An Innovative Model-Based Approach
    Empringham, B.
    Hughes, T.
    Gupta, S.
    Wagner, A.
    Yeh, J.
    Ward, Z.
    Frazier, L.
    Denburg, A.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S434 - S434
  • [44] An investigation into the interaction between drug efficacy and drug price of praziquantel in determining the cost-effectiveness of school-targeted treatment for Schistosoma mansoni using a population dynamic model
    Guyatt, HL
    Chan, MS
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1998, 3 (06) : 425 - 435
  • [45] Model-based evaluation of cost-effectiveness of nerve growth factor inhibitors in knee osteoarthritis: impact of drug cost, toxicity, and means of administration
    Losina, E.
    Michl, G.
    Collins, J. E.
    Hunter, D. J.
    Jordan, J. M.
    Yelin, E.
    Paltiel, A. D.
    Katz, J. N.
    OSTEOARTHRITIS AND CARTILAGE, 2016, 24 (05) : 776 - 785
  • [46] Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: An evidence-based approach
    Hamblin, Susan
    Rumbaugh, Kelli
    Miller, Richard
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2012, 73 (06): : 1484 - 1490
  • [47] Forecasting global essential childhood cancer drug need and cost: An innovative model-based approach.
    Denburg, Avram
    Empringham, Brianna
    Hughes, Terence
    Wagner, Anita K.
    Ward, Zachary J.
    Yeh, Jennifer
    Gupta, Sumit
    Frazier, A. Lindsay
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [48] Which coronary lesions should be treated with a drug eluting stent? A model-based cost-effectiveness analysis
    Carlier, SG
    Berger, A
    De Backer, TL
    Heyndrickx, G
    Wijns, W
    CIRCULATION, 2003, 108 (17) : 408 - 408
  • [49] Economic evaluation of drug-eluting stents:: A systematic literature review and model-based cost-utility analysis
    Kuukasjaervi, Pekka
    Raesaenen, Pirjo
    Malmivaara, Antti
    Aronen, Pasi
    Sintonen, Harri
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (04) : 473 - 479
  • [50] Health outcomes and cost-effectiveness of diversion programs for low-level drug offenders: A model-based analysis
    Bernard, Cora L.
    Rao, Isabelle J.
    Robison, Konner K.
    Brandeau, Margaret L.
    PLOS MEDICINE, 2020, 17 (10)
12345